Truvada, the HIV
prevention drug approved by US health regulators. The opinion of the
Food and Drug Administration is that Truvada can be used by persons at
high risk of disease and anyone who may hold in sexual activity with
HIV-infected partners. There have been concerns the circulation of
such a drug could engender a false sense of security. Present have also
been worries that a drug-resistant strain of HIV could expand.
Studies since
2010 showed that Truvada reduced the risk of HIV in healthy gay men and
among HIV-negative heterosexual partners of HIV-positive people by
between 44% and 73%. A number of health workers and groups active in the
HIV society opposed a green light for the once-daily pill. Truvada,
made by California-based Gilead Sciences, is previously backed by the
FDA to be in use with existing anti-retroviral drugs for people who
contain HIV.
Labels:
Truvada,
US health regulators
No comments:
Post a Comment